Bajaj Healthcare launches generic favipiravir tablets for Covid-19 treatment
New Delhi : Drug firm Bajaj Healthcare on Tuesday announced the launch of its antiviral Favipiravir tablets under the brand name ‘Favijaj‘ used for the treatment of mild to moderate Covid-19 infections in the…
India reaches out to US companies over investment in pharmaceutical, medical devices sector
India has reached out to top American pharma companies seeking investment in the country’s pharmaceutical and medical devices sector, which gains urgency in view of a devastating second wave of the coronavirus pandemic. India’s Ambassador to the…
India records 3,460 deaths as 5 states see highest-ever tolls
Covid deaths surged in the country with five major states reporting their highest daily toll from the pandemic on Tuesday even as the count of fresh cases rose again after…
New Covid cases may peak today, say experts
NEW DELHI: Scientists working on a mathematical model to chart the trajectory of Covid-19 cases have noted that the peak of new infections could be reached within the next 24 hours at…
India’s biggest Serum Vaccine order covered just 4% of people
The Narendra Modi-led federal government hasn’t placed an order larger than 110 million doses from the biggest local maker since sales started in December, according to a person familiar with…
Pharma Industry Warns Of Covid Drug Shortages As Raw Materials Prices Surge 200%
New Delhi : As India struggles with the worst surge in Covid cases since the beginning of the pandemic last year, the price of raw materials used to manufacture key Covid…
SII To Invest Rs 2,400 Crore In Britain As Part Of India-UK Initiative
LONDON : The UK and Indian governments will announce their first enhanced trade partnership on Tuesday as a precursor to a free trade agreement when UK Prime Minister Boris Johnson…
Hyderabad: Bharat Biotech in talks with global MNCs to make Covaxin
HYDERABAD: After sealing a deal with Indian Immunologicals Ltd (IIL) for manufacturing its indigenous Covid-19 vaccine Covaxin, Bharat Biotech is now in parleys with global pharma giants for manufacturing the desi vaccine. While the company has already…
Biocon Biologics provided 7,000 doses of Itolizumab in April
Biocon Biologics, the biosimilar subsidiary of Biocon, provided 7,000 doses of Itolizumab for treatment of Covid-19 patients in April, three times more than last year, and re-aligned its focus to deliver Covid-19 treatment drugs faster, its…
NMMC Issues Notices To Three Hospitals For Asking Patients’ Kin To Arrange Remdesivir
Navi Mumbai : The Navi Mumbai Municipal Corporation (NMMC) has issued show cause notices to three private hospitals for allegedly asking the relatives of COVID-19 patients to arrange Remdesivir injection.…
